Compare FENC & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FENC | RPAY |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 263.3M | 288.0M |
| IPO Year | 2010 | 2018 |
| Metric | FENC | RPAY |
|---|---|---|
| Price | $7.55 | $2.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $15.00 | $6.03 |
| AVG Volume (30 Days) | 115.4K | ★ 1.4M |
| Earning Date | 01-01-0001 | 06-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.67 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $47,538,000.00 | ★ $309,261,000.00 |
| Revenue This Year | N/A | $8.67 |
| Revenue Next Year | $70.78 | $6.08 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $2.69 |
| 52 Week High | $9.92 | $5.98 |
| Indicator | FENC | RPAY |
|---|---|---|
| Relative Strength Index (RSI) | 39.52 | 35.21 |
| Support Level | $7.45 | N/A |
| Resistance Level | $8.27 | $3.87 |
| Average True Range (ATR) | 0.45 | 0.19 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 10.51 | 8.06 |
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segments Consumer Payments and Business Payments.